GIE Medical Granted FDA’s Breakthrough Device Designation for Multi-Stage Drug Coated Balloon to Treat Esophageal Strictures

Designation may provide U.S. patients faster access to groundbreaking technology PLYMOUTH, Minn., June 6, 2023 /PRNewswire/ — GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, was granted designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA) for its ProTractX3™ TTS … Read more